At SalutarisMD, our mission is to make treatment for AMD & other challenging retina diseases available to all, no matter the economic status or geographic location – an affordable, accessible, one-time treatment that can last a lifetime.
Location: United States, Arizona, Tucson
Employees: 51-200
Founded date: 2008
Investors 2
| Date | Name | Website |
| - | Arizona Te... | arizonatec... |
| - | Arizona Te... | azti.membe... |
Mentions in press and media 8
| Date | Title | Description |
| 18.10.2017 | Gemini Therapeutics closes $42.5M Series A for dry age-related macular degeneration therapy | Atlas Venture, Lightstone Ventures and OrbiMed co-led the Series A, according to a news release. They also took part in the seed round last year. James McLaughlin, Gemini Therapeutics cofounder and CEO, said that the company focuses on pati... |
| 24.03.2015 | Startup’s device uses targeted radiation – brachytherapy – to treat macular degeneration | The device’s mechanism is a touch spine-tingling, but it beats the alternative – monthly injections of drugs like Avastin and Lucentis to the eye. Such drugs have limited efficacy among patients. Current clinical trials for wet AMD run the ... |
| 07.11.2013 | Arizona healthcare startup raises $50K for its wet AMD treatment | “Brachytherapy for wet AMD has the potential, as a one time treatment, to drive efficacious outcomes as well as reduce the need for anti-VEGF injections.” This, he said, could take the cost out of care as the anti-VEGF injections, the bi-mo... |
| 04.11.2013 | Healthcare startup with noninvasive, one-time wet AMD treatment touts two years of success | Anti-VEGF therapy proved to be a major breakthrough in treatment for wet AMD. The drugs could halt the progression of the disease and even recapture some lost vision, Taylor said. But the drugs are a chronic therapy. “The patient should go ... |
| - | Gemini Therapeutics closes $42.5M Series A for dry age-related macular degeneration therapy | Fundus photo of macular scarring with normal blood vessels and optic nerve Gemini Therapeutics has closed a Series A round to advance its precision medicine therapy for dry age-related macular degeneration. The Cambridge, Massachusetts comp... |
| - | Healthcare startup with noninvasive, one-time wet AMD treatment touts two years of success | Oraya Therapeutics, one of California’s many healthcare startups, has distinguished itself from the crowd. The medical device company recently presented results from a two-year study showing its IRay, a low-voltage, stereotactic, radiosurgi... |
| - | Arizona healthcare startup raises $50K for its wet AMD treatment | Tucson, Ariz.-based healthcare startup Salutaris Medical Devices has raised $50,000 in debt financing so far in its quest to reach $1 million, according to a regulatory filing made with the SEC. The funding will support the 5-year-old compa... |
| - | Startup’s device uses targeted radiation – brachytherapy – to treat macular degeneration | One of the most commonly prescribed drugs for wet age-related macular degeneration is Avastin – a cancer drug. So it’s not that surprising that a new approach for wet AMD is radiation therapy – with aims to halt the growth of the unruly blo... |